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Abstract
Major depressive disorder (MDD) is a common disorder with a variety of symptoms including mood alterations,
anhedonia, sleep and appetite disorders, and cognitive disturbances. Stressful life events are among the strongest risk
factors for developing MDD. At the cellular level, chronic stress results in the modification of dendritic spine
morphology and density. Here, we study the role of Pyk2 in the development of depressive-like symptoms induced by
a model of chronic unpredictable mild stress (CUMS). Pyk2 is a non-receptor calcium-dependent protein-tyrosine
kinase highly expressed in the forebrain principal neurons and involved in spine structure and density regulation. We
show that Pyk2 knockout mice are less affected to anxiety-like and anhedonia-like phenotypes induced by the CUMS
paradigm. Using region-specific knockout, we demonstrate that this phenotype is fully recapitulated by selective Pyk2
inactivation in the amygdala. We also show that in the absence of Pyk2 the spine alterations, PSD-95 clustering, and
NMDA receptors changes induced by the CUMS paradigm are prevented. Our results reveal a possible role for Pyk2 in
the response to stress and in synaptic markers expression and spine density regulation in the amygdala. We suggest
that Pyk2 contributes to stress-induced responses through micro-structural changes and that its deficit may contribute
to the resilience to chronic stress.
Introduction
Major depressive disorder (MDD) is a debilitating dis-
ease characterized by low mood, loss of interest in outside
stimuli, impaired cognitive function, and vegetative
symptoms, such as disturbed sleep or appetite1. MDD is a
multifactorial and clinically heterogenous mental disorder
with a percentage of heritability estimated around 35%
and yearly incidence of 6% of affected individuals among
the adult worldwide population2. Chronic life stressors are
among the main risk factors for developing a major
depressive syndrome3. Notably, a clear association
between stressors and the emergence of major depressive
episodes has been demonstrated among dysthymic
patients4. The impact of stressors depends on the char-
acteristics of the stressor itself (e.g. severity, chronicity,
predictability), coping ability, and individuals’ stressor
history (including early life trauma)3,5–7.
A large body of evidence shows that in animal models
depression is closely associated to microstructural
alterations in dendritic spines morphology and spine
density8. Indeed, chronic stress results in decreased den-
dritic spine density in hippocampus and prefrontal cortex,
and an increased spine density in amygdala and nucleus
accumbens9–12. Therefore, understanding dendritic
spines dynamics and turnover and identifying master
molecules regulating this phenomenon is crucial for
uncovering the mechanisms underlying stress-induced
depression.
Pyk2 could be one of these master molecules. Pyk2 is
a non-receptor tyrosine kinase that can be activated by
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Ca2+ and is highly expressed in cortex, amygdala, stria-
tum, and hippocampus13,14. Previous findings indicated a
role for Pyk2 in the regulation of hippocampal synaptic
plasticity15–17. Our recent work with Pyk2 mutant mice
showed its importance in vivo for spatial learning and
memory, synaptic plasticity and spine density, and mor-
phology18. Yet, the role of Pyk2 in the physiopathology of
MDD remains largely unexplored as only two reports
have pointed out a possible role of Pyk2 in this context.
First, it has been reported that a model chronic stress in
mice increases the colocalization of Pyk2 with NUP62, a
nucleoprotein involved in chromatin organization and
transcription19. The increased colocalization results in an
increased phosphorylation of NUP6219 suggesting a
potential role of Pyk2 in mediating depressive-like
symptomatology after chronic stress via the indirect reg-
ulation of gene transcription. A second study demon-
strated that, in a model of chronic stress in rats, the over-
expression of Pyk2 in the lateral septal nucleus has a
positive effect on the forced swimming test’s perfor-
mance20, a common paradigm to evaluate behavioral
despair in rodents, one of the symptoms of MDD21.
Finally, a recent genome wide association study (GWAS)
indicated that the PTK2B gene is significantly associated
with neuroticism22 which in turn is a common risk factor
to develop MDD23. Despite these early results, the rele-
vance of the tyrosine kinase Pyk2 in the pathophysiology
of MDD is not known. Understanding in which brain
region and through which molecular mechanism Pyk2
regulates depressive symptoms would provide important
insights on the possible role of PyK2 in MDD.
We recently generated full knockout mice for the
PTKB2 gene, as well as mice with floxed PTK2B alleles,
which permit to inactivate the gene in discrete brain
regions or cell types13,18. Mice were exposed to the
chronic unpredictable mild stress (CUMS) paradigm to
induce depressive-like symptoms. The CUMS protocol
overcomes the stress habituation and has been widely
used to model depression-like behaviors8,24. As expected,
we observed that CUMS induced a severe depressive-like
performances in the stressed mice as compared to non-
stressed controls. Observed phenotypes included;
decreased time spent in the open arms in the plus maze,
decreased time struggling in the forced swimming test,
and decreased preference for sweet water in the sucrose
preference test as described previously25. Surprisingly,
compared to WT mice, Pyk2-deficient mice showed
reduced behavioral sequelae induced by the CUMS
paradigm in several tests. Region-specific KO studies
showed a major role of Pyk2 in the basolateral nuclei of
the amygdala. We also examined spine density in this
brain region and found that stress-induced spine altera-
tions were absent in Pyk2-deficient mice. These results
underline the possible role of Pyk2 in depressive states
induced by stress.
Materials and methods
Detailed descriptions and procedures for genetically
modified mice, CUMS paradigm, open field test, elevated
plus maze test, forced swimming test, sucrose preference
test, viral constructs and stereotaxic injection, tissue
preparation and immunofluorescence, confocal imaging
and analysis, Golgi staining and spines analysis, immu-
noblot analysis and statistical analysis are provided in the
Supplementary Methods section.
Results
Effects of CUMS paradigm in mice lacking PTK2B gene
(Pyk2−/− mice)
Pyk2+/+ and Pyk2−/− mice were exposed for 28 days to
randomized and unpredictable aversive stimuli (CUMS
protocol, see Materials and methods and supplementary
figure 1a). After the CUMS protocol all mice were eval-
uated for behavioral alterations. Naive mice from both
genotypes (Pyk2+/+ and Pyk2−/−) were used as controls.
First, as a general health index, we also monitored the
body weight and we observed no difference in any group
as compared to Pyk2+/+ controls (Fig. 1a). Next, we used
the open field to evaluate time spent in the center of the
arena and pathlengths in Pyk2+/+ and Pyk2−/− mice
exposed (Pyk2+/+:CUMS and Pyk2−/−:CUMS) or not to
CUMS (control Pyk2+/+ and Pyk2−/− mice). All groups of
mice habituated well and showed no difference in path-
lengths (Fig. 1b) during the 30-min session. However,
Pyk2+/+:CUMS but not Pyk2-/-:CUMS mice displayed
significantly reduced time in the center in the open field
paradigm (Fig. 1c). We then subjected the mice to the
forced swimming test (FST). We measured the time
during which mice were mobile to escape from the water:
stressed mice showed lower levels of time struggling as
compared to their respective controls without CUMS. No
difference was observed when comparing Pyk2+/+ and
Pyk2−/− control mice or Pyk2+/+:CUMS and Pyk2−/−:
CUMS mice (Fig. 1d). We also analyzed the two first
minutes of the assay and no changes were observed when
comparing Pyk2+/+ and Pyk2−/− control mice or Pyk2+/+:
CUMS and Pyk2−/−:CUMS mice (Fig. 1e). Next, we used
an elevated plus maze to evaluate the effect of the CUMS
paradigm on time spent in the open arms in the four
groups of mice (Fig. 1f, g). We found a significant pre-
ference for the open arms of the Pyk2+/+ control mice as
compared to the Pyk2+/+:CUMS (Fig. 1f). Interestingly
this difference was lost when comparing control Pyk2−/−
mice to Pyk2−/−:CUMS, which all spent a comparable
amount of time as the Pyk2+/+ controls in exploring the
open arm. Importantly the locomotor activity (measured
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as a pathlength) tested in the plus maze was similar in all
groups (Fig. 1g). Finally, we evaluated the effect of the
genotype on potential CUMS-induced changes in the
sucrose preference test. Animals were tested for 3 con-
secutive days for their preference for sweet water
(2% sucrose) versus plain water (Fig. 1h). Control Pyk2+/+
mice displayed high levels of preference towards sweet
water as compared to normal water. In contrast, although
they still had some preference for sweet water, Pyk2+/+:
CUMS mice displayed a significantly reduced preference
Fig. 1 Behavioral effects of CUMS in Pyk2+/+ and Pyk2−/− mice. a Body weight was monitored as a measure of general health. Two-way ANOVA,
genotype effect: F(1, 51)= 2.19, p= 0.09. b Pathlength traveled in an open field apparatus during 30 min. Two-way ANOVA, genotype effect: F(3, 52)=
0.303, p= 0.82. c Time in the center in an open field apparatus during 30 min. Two-way ANOVA, interaction effect: F(1, 52)= 6.956, p= 0.011. d Forced
swimming test: % of time struggling from the 3rd to the 6th minute in a 6-min long session. Two-way ANOVA, genotype effect: F(1, 52)= 21.72, p <
0.0001. e Forced swimming test: % of time struggling from the 1st to the 2nd minute in a 6-min long session. Two-way ANOVA, genotype effect:
F(1, 52)= 54.33, p < 0.0001. f Time spent in the open arms of an elevated plus maze. Two-way ANOVA, genotype effect: F(1, 52)= 4.14, p= 0.01. g Path
length traveled in the elevated plus maze. Two-way ANOVA, genotype effect: F(1, 52)= 2.24, p= 0.078. h Sucrose preference test. Preference for sweet
water over plain water (%). Three consecutive days of testing were evaluated in the sucrose preference test. Two-way ANOVA genotype effect: day 1,
F(1, 52)= 11.20, p= 0.0015; day 2, F(1, 52)= 10.73, p= 0.0019; day 3, F(1, 52)= 7.42, p= 0.008. Data are means+ SEM. Control Pyk2
+/+ (n= 14); control
Pyk2−/− (n= 14); Pyk2+/+:CUMS (n= 13) and Pyk2−/−:CUMS (n= 15). Tukey’s post hoc test was used in all experiments. c–h: *p < 0.05, **p < 0.01,
and ***p < 0.001 compared to Pyk2+/+ controls. CUMS Chronic unpredictable mild stress group
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as compared to Pyk2+/+ unstressed controls. Intriguingly,
Pyk2−/− and Pyk2−/−:CUMS groups of mice showed a
comparable preference for sweet water, with no difference
from that observed in control Pyk2+/+ mice. This set of
results indicates that behavioral alterations induced by the
CUMS paradigm in Pyk2+/+ mice were almost completely
absent in Pyk2−/− mice in the same conditions. In con-
trast, the performance in the forced swimming test was
not affected.
Pyk2 inactivation in the amygdala is sufficient to mimic the
Pyk2−/− mice phenotype after CUMS
To gain insight on the brain region that could mediate
such behavioral changes we knocked out Pyk2 in the
neurons of selected brain regions by injecting Pyk2f/f mice
with AAV expressing a Cre recombinase under the con-
trol of CaMKII promoter (AAV-CaMKII-Cre-GFP).
Control AAVs expressed only GFP (AAV-CaMKII-GFP).
AAV-CaMKII-Cre-GFP and control viruses were
Fig. 2 Consequences of the regional-specific ablation of Pyk2 on the behavioral effects of CUMS. a Pathlength traveled in an open field
apparatus during a 30 min session. Two-way ANOVA, genotype effect: F(5, 74)= 5.42, p= 0.0003. b Time in the center in an open field apparatus
during 30 min. One-way ANOVA, genotype effect: F(5, 76)= 2.349, p= 0.0488. c Forced swimming test: % of time struggling from the 3rd to the 6th
minute in a 6-min long session. One-way ANOVA: F(5, 76)= 20.83, p < 0.0001. d Forced swimming test: % of time struggling from the 1st to the 2nd
minute in a 6-min long session. One-way ANOVA: F(5, 76)= 45.34, p < 0.0001. e Elevated plus maze test, time spent in open arms, One-way ANOVA
and Tukey’s post hoc test: F(5, 76)= 4.396, p= 0.001. f Pathlength traveled in the elevated plus maze. One-way ANOVA and Tukey’s post hoc test:
F(5, 76)= 1.19, p= 0.32. g Sucrose preference test: Preference for sweet water over plain water (%). Three consecutive days of testing were evaluated
in the sucrose preference test. One-way ANOVA: day 1, F(5, 79)= 2.91, p= 0.018; day 2: F(5, 79)= 7.34, p < 0.0001; day 3: F(5, 79)= 3.86, p= 0.003. Post-
hoc Tukey’s test. Data are means+ SEM. a–g GFP group (n= 10); CUMS-GFP group (n= 13); CUMS-mPFC group (n= 15); CUMS-Nacc group (n= 15);
CUMS-Hipp group (n= 15); CUMS-Amy group (n= 14). *p < 0.05 and **p < 0.01 compared to unstressed GFP group and $p < 0.05 compared to
CUMS-GFP group
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bilaterally injected either in the amygdala (CUMS-Amy
group), or the medial prefrontal cortex (CUMS-mPFC
group), or the nucleus accumbens (CUMS-NAc group),
or the hippocampus (CUMS-Hip group). Three weeks
after surgery, all the groups of mice were exposed to the
CUMS protocol. The GFP group of mice was injected in
one of the four aforementioned brain regions with AAV-
CaMKII-GFP, but not exposed to CUMS. For more clarity
see supplementary figure 1b. First, we verified the correct
coordinates of the injection sites (supplementary figure
2a), and the effects of to the local deletion of the PTK2B
gene on reduction of Pyk2 protein levels in the injection
site by immunofluorescence (supplementary figure 2b–e).
Our results showed a clear decrease or disappearance of
Pyk2 immunoreactivity in the AAV-Cre-targeted brain
regions.
Next, after 28 days of CUMS all groups of mice were
evaluated in a battery of behavioral tests namely open field
test, plus maze test, forced swimming test, and sucrose
preference test. Concerning the general locomotor activ-
ity, all groups of mice habituated well and showed equal
levels of locomotor activity in the open field except for the
CUMS-Amy group which showed increased pathlengths
but normal habituation (Fig. 2a). Regarding to the para-
meter time in the center, all the groups of mice displayed
reduced time in the center of the arena when compared
with the GFP group with the exception of the CUMS-
Amy group (Fig. 2b). We then used the forced swimming
test in all the groups (Fig. 2c). Regardless of the regional
deletion, all groups of mice exposed to CUMS struggled
much less than the unstressed GFP group confirming that
the changes in the levels of Pyk2 in any tested brain region
had no effect on the performance in the forced swimming
test. We also analyzed the two first minutes of the assay
and again all groups of mice exposed to CUMS struggled
much less than the unstressed GFP group (Fig. 2d). Then,
the elevated plus maze was performed in all groups of
mice (Fig. 2e). As compared to all the other groups, the
CUMS-GFP group spent the lowest time in the open
arms. The CUMS-NAc group displayed reduced time in
the open arms similar to those of CUMS-GFP mice. In
contrast, the CUMS-Amy group had levels of open arms
exploration close to those of unstressed GFP controls, and
significantly different from those of the CUMS-GFP
group. Finally, the CUMS-mPFC and CUMS-Hip groups
showed intermediate alterations regarding to the time
spent in open arms. These results did not appear to
depend on general locomotor activity in the plus maze as
shown in Fig. 2f. This was a discrepancy from the CUMS-
Amy group when comparing the locomotor activity
parameter in the elevated plus maze and in the open field
test. The CUMS-Amy group showed hyper locomotion
only in the latter. This discrepancy with the elevated plus
maze is likely due to the fact that the open field is more
useful for locomotor measurements than it is to anxiety
and elevated plus maze is more useful for anxiety-like
measurements than it is to locomotor behavior26,27.
Altogether, these results indicate that the CUMS-Amy
group was the less affected by the CUMS protocol in
parameters evaluated by the elevated plus maze and open
field test. Finally, we tested in all six groups of mice their
preference for sweet (2% sucrose) or plain water, as in
Fig. 1h (Fig. 2g). As expected, control GFP mice exhibited
the highest level of preference towards palatable water in
the presence of both plain and sucrose-water. In contrast,
although the CUMS-GFP mice had some preference for
sweet water, this preference was significantly reduced as
compared to GFP CUMS-naive controls. CUMS-mPFC,
CUMS-Hip, and CUMS-NAc displayed similarly low
levels of sucrose preference as compared to CUMS-GFP
and significantly reduced preference when compared with
the GFP group during the first 2 days of testing. Inter-
estingly the CUMS-Amy group was the only group
showing indistinguishable levels of sucrose preference as
compared to GFP mice indicating that CUMS did not
affect the preference towards the sweet water in this
group of mice. In summary, the present results show that
the reduced sequelae displayed by full Pyk2−/− knockout
mice after the CUMS protocol was completely mimicked
when Pyk2 expression was specifically removed in the
amygdala.
Pyk2 levels and its activation are not altered by stress in
the amygdala
To address the molecular mechanisms underlying the
phenotype showed by the mice lacking PyK2 in the
amygdala, we measured Pyk2 total protein levels and its
phosphorylation at Tyr-402, the autophosphorylation
site28, a good indicator of its kinase activity, in the
amygdala of Pyk2+/+ mice subjected to 28 days of CUMS
vs. naive control Pyk2+/+. When animals were sacrificed
24 h after the end of the CUMS protocol, we did not
observe any change either in the total levels of Pyk2
(Fig. 3a, b) nor in phosphoTyr-402-Pyk2 (Fig. 3a, c). We
then hypothesized that the changes in the total or
phospho-Pyk2 levels might be more acute and/or transient
or that they could take place earlier after the exposure of
the mice to stress. Thus, we designed a new experiment in
which Pyk2+/+ mice were acutely stressed by subjecting
them to an hour restrain. Mice were sacrificed 0 or 3 h
after the restrain protocol and the amygdala was quickly
dissected out. Unstressed Pyk2+/+ mice were used as
controls. Again, no change in either total Pyk2 (Fig. 3d and
e) or phosphoTyr-402-Pyk2 (Fig. 3d, f) was observed in the
stressed Pyk2+/+ mice as compared to control mice. In
summary, these results show that neither acute stress nor
CUMS alter Pyk2 levels or autophosphorylation in a
manner that is detectable at the tissue level.
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Excitatory synapses in principal neurons of the basolateral
amygdala (BLA) are increased during CUMS in Pyk2+/+ but
not in Pyk2−/− mice
Pyk2 has functions that are dependent on its kinase
activity and others that are more related to other prop-
erties, such as scaffolding15,18,19. In our previous work we
observed that the decreased spine density in Pyk2−/−
hippocampal neurons is rescued by Pyk2 re-expression
independently of its kinase activity18. Chronic stress and
subsequent depression-like phenotype correlate with an
increase in dendritic spines in the principal neurons of the
BLA nuclei8. We therefore investigated whether the lack
of Pyk2 in the amygdala could prevent the formation of
these new dendritic spines. We used Golgi staining in a
sub-set of Pyk2+/+, Pyk2−/− control mice, as well as in
Pyk2+/+:CUMS and Pyk2−/−:CUMS mice that were
sacrificed 24 h after the last day of CUMS to study the
spine density in the principal projection neurons of the
BLA. First, our analysis confirmed the previous reports
showing that dendritic spine density was significantly
increased in Pyk2+/+ mice, 10 days after the CUMS
protocol, as compared to Pyk2+/+ controls (Fig. 4a, b). In
contrast, this stress-induced effect was completely absent
in Pyk2−/−:CUMS mice compared to Pyk2-/- control mice
(Fig. 4a, b). To further explore the role of Pyk2 we per-
formed a double immunofluorescence in Pyk2+/+ and
Pyk2+/+:CUMS mice to study whether Pyk2 translocates
and colocalizes with PSD-95 after chronic stress as pre-
viously published in stimulated pyramidal neurons of the
hippocampus15. CUMS induced a clear increase in Pyk2
and PSD-95 colocalization (Fig. 4c–e). We then evaluated
the PSD-95 dynamics in response to CUMS and counted
the number of PSD-95 clusters, which correspond to
post-synaptic densities, in the BLA of wild type and
Pyk2−/− mice. In Pyk2+/+ mice CUMS increased the
number of PSD-95-positive clusters per field as compared
to Pyk2+/+ controls (Fig. 4f, g). In Pyk2-/- mice the CUMS
protocol also increased the number of PSD-95-positive
particles, but this effect was significantly less pronounced
as compared to Pyk2+/+:CUMS mice (Fig. 5f, g)
Fig. 3 Lack of effect of stress on the total levels and phosphorylation of Pyk2. a–c Wild type mice subjected or not to a 28-day CUMS protocol
(from Fig. 1) and sacrificed 10 days later (after the behavioral assessment was ended). a Immunoblotting analysis of Pyk2 and its activated form
autophosphorylated on Tyr402 (pY402-Pyk2) and tubulin as a loading control. b Densitometric quantification of total Pyk2 as in a. Two-tailed
Student’s t-test: t17= 1.24, p= 0.23. c Densitometric quantification of pY402-Pyk2 as in a. Two-tailed Student’s t-test: t17= 1.31, p= 0.19. In b and
c data were normalized to tubulin for each sample and expressed as percentage of Pyk2+/+ controls. d–f Another set of wild type mice were
subjected or not to acute restraint stress and sacrificed immediately (0 h) or 3 h later. d Immunoblotting analysis of Pyk2, pY402-Pyk2, and tubulin as a
loading control. e Densitometric quantification of total Pyk2 results as in d. One-way ANOVA: F(2, 14)= 0.88, p= 0.43. e Densitometric quantification of
pY402-Pyk2 as in d. One-way ANOVA: F(2, 14)= 0.44, p= 0.66. Data are means+ SEM. Tukey’s post hoc test was used in e and f. In b, c, e, and f, data
were normalized to tubulin and expressed as percentage of Pyk2+/+ unstressed controls. In a–c n= 9 mice/group; in d–f n= 5–6 mice per group. In
a and d molecular weight markers position is indicated in kDa
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Fig. 4 Pyk2 knockout prevents the changes in dendritic spines and PSD-95 induced by chronic stress in the amygdala. a Golgi-Cox-stained
apical dendrites of a basolateral amygdala principal neuron from Pyk2+/+ and Pyk2−/− unstressed control mice and in Pyk2+/+:CUMS and Pyk2−/−:
CUMS mice. The images are negatives for better visualization. Scale bars, 15 and 3 µm, respectively. b Quantification of spine density in dendrites as in
a. Two-way ANOVA, interaction, F(1, 261)= 17.92, p < 0.0001, Bonferroni’s post hoc test (55–60 dendrites from 5 mice per group). c Confocal images
of the basolateral nucleus of the amygdala sections from Pyk2+/+ controls and Pyk2+/+ mice after CUMS immunolabelled for PSD-95 (green)
and Pyk2 (red). We analyzed 1 image per slice, three slices per mouse, seven mice per group. Scale bar, 4 µm. d and e Quantification of results as in c.
d Number of Pyk2-positive puncta per field, Student’s t-test; t= 0.69, p= 0.5. e Number of Pyk2/PSD-95-double-positive puncta per field, Student’s
t-test, t= 2.52, p= 0.026. f PSD-95-positive puncta in the basolateral nucleus in Pyk2+/+ and Pyk2−/− control mice and in Pyk2+/+:CUMS and Pyk2−/
−:CUMS mice. Scale bar, 3 μm. g Quantification of PSD-95-positive puncta in basolateral nucleus as in f. Two-way ANOVA, interaction, F(1, 33)= 9.53, p
< 0.004; stress effect F(1, 33)= 27.71, p < 0.0001, Bonferroni’s post hoc test (1 image per slice, three slices per mouse, 8–9 mice per group). Data are
means+ SEM. ***p < 0.001 compared to Pyk2+/+ unstressed controls, &&&p < 0.001 compared to Pyk2+/+:CUMS, and $$p < 0.01 compared to Pyk2−/−
controls
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confirming the hypothesis that the increase in PSD-95
clusters due to chronic stress is significantly weaker in
Pyk2−/− mice.
N-methyl-D-aspartate receptors (NMDARs) alterations in
the amygdala after CUMS are Pyk2-dependent
The increase of Pyk2/PSD-95 colocalization in the BLA
after CUMS was coincident with both the clustering of
PSD-95 at excitatory synapses and the increase in spine
density in the BLA. We therefore hypothesized that the
increase in the post-synaptic density scaffold could cor-
respond to changes in the NMDARs in the principal
neurons of the BLA. To test this hypothesis, we evaluated
by immunoblotting the total and phosphorylated levels of
several NMDAR subunits in the amygdala of Pyk2+/+:
CUMS and Pyk2-/-:CUMS mice and we compared the
results with those obtained in Pyk2+/+ and Pyk2−/−
controls. First, total NMDA receptors GluN1 and
GluN2A levels were not changed in mice subjected to
CUMS as compared to control mice (Fig. 5a, b). In con-
trast, we observed an increase in GluN2B total protein
levels in Pyk2+/+:CUMS as compared to Pyk2+/+ mice.
The increase in GluN2B was negligible when comparing
Pyk2−/−:CUMS with Pyk2−/− mice. The phosphorylated
forms, pS896-GluN1 and pY1472-GluN2B were also
increased in Pyk2+/+:CUMS compared to Pyk2+/+ con-
trol mice (Fig. 5c, d). When we calculated the ratio
pY1472-GluN2B/GluN2B the increase disappeared (data
not shown) indicating that increased pY1472-GluN2B
levels were due to a general up-regulation of the GluN2B
protein subunit. In Pyk2-/-:CUMS mice however, these
changes were completely abolished when compared to
Pyk2−/− mice. These results indicate that, in wild type
mice, CUMS induced a long-lasting change in the prop-
erties of excitatory synapses in the BLA, which was
apparent as an increase in the Ser896 phosphorylation of
GluN1 and in the GluN2B protein levels. In contrast these
changes were prevented in the absence of Pyk2, revealing
Fig. 5 Pyk2 knockout prevents the changes in NMDA receptors levels and phosphorylation induced by chronic stress in the amygdala.
NMDARs were studied by immunoblotting in Pyk2+/+ and Pyk2−/− mice unstressed (Control) or 10 days after being subjected to a CUMS paradigm.
a Immunoblotting analysis of GluN1, GluN2A, GluN2B, and tubulin as a loading control. b Densitometric quantification of results as in a. Two-way
ANOVA interaction, GluN1, F(1, 30)= 0.33, p= 0.95, GluN2A, F(1, 30)= 1.14, p= 0.70, GluN2B, F(1, 30)= 6.04, p= 0.02, Tukey’s post hoc test. c
Immunoblotting analysis of pS896-GluN1, pY1325-GluN2A, pY1472-GluN2B, and tubulin as a loading control. d Densitometric quantification of results
as in c. Two-way ANOVA interaction, pS896-GluN1, F(1, 29)= 5.75, p= 0.02; pY1325-GluN2A, F(1, 29)= 0.42, p= 0.51, pY1472-GluN2B, F(1, 29)= 7.35, p=
0.01, Tukey’s post hoc test. Data are means+ SEM. In all experiments n= 8–9 mice per group. From a to d: *p < 0.05 compared to Pyk2+/+ unstressed
controls. In a and c molecular weight markers position is indicated in kDa
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the key role of this protein in synaptic adaptations in
response to chronic stress.
Discussion
Here, we show the role of Pyk2 in the response to a
model of chronic stress. We showed that although in basal
conditions (i.e. in the absence of stress) the absence of
Pyk2 does not modify the responses in anxiety-like and
depression-like behavioral tests, PyK2 ablation in the
adult confers a marked resistance to the sequelae induced
by CUMS, as shown by the normal performances in the
plus maze and sucrose preference tests. We also identified
the amygdala as a core structure in the modulation of the
observed phenotype in Pyk2-deficient mice. Importantly,
we provide evidence for a key role of Pyk2 in the reg-
ulation of dendritic spine density in the projection neu-
rons of the BLA, with a concomitant PSD-95 stabilization
at synapses. Accordingly, the modifications of NMDARs
were prevented in the amygdala of Pyk2-deficient mice
exposed to the CUMS paradigm. The ensemble of those
results strongly indicates a role of Pyk2 in regulating the
structural plasticity upon chronic stress.
Interestingly, we observed a dissociation in the Pyk2-
dependence of different components of the behavioral
alterations induced by CUMS. We observed that in full
Pyk2 knockout mice the CUMS protocol failed to induce
a reduction of sucrose preference, as well as a decrease on
the exploratory behavior in the open arms of the elevated
plus maze. In order to identify the regions mainly impli-
cated in the reduced alterations induced by CUMS we
focused on the brain areas showing the highest levels of
Pyk2 expression, and that are associated to chronic stress
and major depression: medial prefrontal cortex, nucleus
accumbens, hippocampus, and amygdala8,13,20,29–31. We
identified the amygdala as the brain region mostly
implicated in the absence of alterations (detected by the
plus maze and sucrose preference tests) after CUMS in
Pyk2-deficient mice. In other words, Pyk2 deletion in
amygdala neurons was sufficient to prevent the sequelae
induced by the CUMS paradigm.
It is well known that a history of repeated or prolonged
stress often leads to hyperactivity of the amygdala32–34.
Furthermore, human studies show that depression and
anxiety are also associated with amygdala hyperactivity35–38.
In animal models, the BLA has emerged as a target for the
effects of repeated stress in a range of anxiety and
depressive behaviors. Furthermore, these behavioral
abnormalities are associated with hyperactivity of BLA
neurons resulting from an increased excitatory input to
those neurons39–43. The increase in the excitatory
synaptic inputs to BLA after repeated stress correlates
with an increase in dendritic spines and dendritic
length44–46. Pyk2, is a tyrosine kinase involved in both the
induction and maintenance of synaptic plasticity, in the
regulation of dendritic spines density and morphology,
and in the formation of memory traces17,18. Our results
show that Pyk2 plays an important role in the structural
plasticity induced by the CUMS paradigm in the neurons
of the BLA, including the increase in dendritic spines.
Importantly, the amygdala can sense a stressful event and
generate an appropriate response to it; however, the
dysfunction of this mechanism might lead to the devel-
opment of a major depression31. Thus, our hypothesis is
that the inactivation of Pyk2, principally in the amygdala,
would lead to the alteration of the processing of the
stressful stimuli turning the animal “resistant” to
anhedonia-like and anxiety-like phenotypes.
Regarding to the unchanged levels of phosphorylation
of Pyk2 in the amygdala after CUMS or acute stressful
stimuli, we hypothesize that there could be different
interpretations. First, Pyk2 could be transiently activated
in few dozens of minutes following stress and return to a
basal activity after 1 h. If so, our methods were unsuitable
for the detection of such activity. A second interpretation
is that the role of Pyk2 that we observed in the stress-
activated pathway could rely on the phosphorylation/
dephosphorylation of another residue than the Tyr-402.
Our group has already shown in hippocampal slices that
depolarization induces a calcineurin-dependent nuclear
translocation of Pyk2 involving the dephosphorylation of
Ser-77847. Finally, one can also hypothesize that the
function of Pyk2 in response to stress does not need an
increased activation of itself compared to basal level. If so,
we can imagine the involvement of interactors of Pyk2
which regulate its substrate specificity or limit its acces-
sibility towards a subset of its substrates by anchoring
Pyk2 in a specific subcellular localization. As an example,
cyclin-dependent kinases (CDKs) perfectly illustrate this
type of regulation. Interaction of CDKs with cyclins can
help to target their activity toward precise substrates, or to
limit their accessibility by shuttling them to a cellular
compartment, such as the Golgi apparatus or nucleus48.
In this line, we hypothesize that there is a necessary role of
Pyk2 at synapses without a need for an increased activa-
tion. It can also be related to kinase-independent func-
tions of Pyk2, which we previously showed to be sufficient
for regulating spine number in hippocampal neurons in
culture in response to glutamate stimulation18,19. In the
hippocampus Pyk2 interacts with PSD-9515,49. We did
show that Pyk2 stabilizes PSD-95 in the excitatory
synapses and regulates synaptic plasticity18. PSD-95
anchors essential proteins, including NMDARs, which
are implicated in the regulation of excitatory synapses
plasticity50, and in the control of the number and mor-
phology of dendritic spines51. We showed an increased
Pyk2/PSD-95 colocalization in the amygdala of the
chronically stressed mice concomitant with an increase in
the number of puncta positive for PSD-95. We also
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observed an increase in GluN2B and pSer896-GluN1
induced by CUMS and prevented in the absence of Pyk2.
Since Pyk2 is a tyrosine kinase, which cannot be directly
responsible for Ser896-GluN1 phosphorylation, these
changes rather indicate the role of Pyk2 in the main-
tenance or function of excitatory synapses during the
processes described here. The role of Pyk2 is likely to be,
in part, related to its interaction with PSD-95.
Supporting our results, several studies showed that
PSD-95 is essential for the maintenance of long-lasting
fear memories via remodeling excitatory synapses52 and
that both NMDARs subunits and PSD-95 are increased in
the amygdala of postmortem samples from patients with
MDD53. The increase in GluN1 Ser896 phosphorylation
and in the number of GluN2B subunits phosphorylated
on Tyr1472 we observed after CUMS suggests an
enhanced NMDAR function with increased channel
opening probability, calcium influx, and receptor
recruitment to the membrane54. NMDAR was shown to
play an essential role in the aforementioned hyperactiva-
tion of the amygdala upon chronic stress and in the
subsequent formation of new excitatory synapses55,56.
Since the synaptic changes in the amygdala were pre-
vented in the absence of Pyk2, this kinase appears to be a
core molecule mediating the effects of chronic stress.
Intriguingly, we show that the Pyk2-deficient mice
behaved as the non-stressed controls in the sucrose pre-
ference test but not in the forced swimming test. It is
known that a missing response to a reward stimulus is the
behavioral correlate of the anhedonia, a core clinical
symptom of the depression. When looking at our results
we should consider that, although the amygdala is widely
accepted as important for the recognition of negative
emotions such as fear57,58, several works in animal mod-
els, as well as in humans point out the involvement of this
region in processing of positive emotions59,60. There is
evidence that the amygdala has a role in the processing
stimulus—reward learning by interacting with the cortico-
limbic and meso-limbic systems. This is particularly true
for the lateral amygdala that seems to be especially
important for the association of a value to the reward. For
example, in animals lesioned in basolateral but not central
amygdala61 we can prevent the normal loss of the
response to a stimulus predicting a food reward when
paired to a malaise-induced injections of lithium chlor-
ide62. We could hypothesize that one possible explanation
of our results could be a preferential effect of the deletion
of PTK2B in the amygdala in tests tracking the effect of
chronic stress of more reward-related symptoms rather
than measuring the behavioral despair, that in the other
hand could be more related to other regions of the brain.
Partially supporting this idea one study showed that in
rodents, the level of 5-HT release following a forced swim
test is reduced in hippocampus, nucleus accumbens, and
cortex but not in the amygdala63. However, the most
obvious explanation for this lack of changes in the forced
swimming test is that Pyk2 might not be important for its
principal and underlying molecular/physiological pro-
cesses. Another divergence in our work comes from the
CUMS-Amy group when comparing the locomotor
activity parameter in the elevated plus maze and in the
open field test. The CUMS-Amy group showed hyper
locomotion only in the latter. This discrepancy with the
elevated plus maze is likely due to the fact that the open
field is more useful for locomotor measurements than it is
to anxiety-like behaviors and elevated plus maze is more
useful for anxiety-like measurements than it is to loco-
motor behavior26,27. Thereby, intrinsic differences of the
apparatus make the open field test more sensitive to
changes in locomotor activity than elevated plus maze.
Accordingly, other discrepancies between the open field
and the elevated plus maze have been previously repor-
ted64–67. Finally, we found that mice with deletion in the
medial prefrontal cortex and hippocampus showed
decreased preference for sweet water in the first trials of
the sucrose preference test, but they finally became
unaffected in the trial number 3. One possible reason is
that the two regions seem to contribute together to the
short-term memory68. Indeed, we already showed in a
previous paper that Pyk2 is involved in the regulation of
memories mediated by the hippocampus18. Therefore, we
hypothesize that deletion of Pyk2 in the hippocampus or
the medial prefrontal cortex could induce mnemonic
alterations that would lead to a faster habituation/accep-
tation of the sweet solution.
In conclusion, recent large-scale human genetic studies
have identified PTK2B as a gene associated with neuro-
ticism22 which in turn is a risk factor to develop MDD23.
Here we propose for the first time a potential mechanism
that could explain the human association of PTK2B to the
risk to develop depression after chronic stress. Our results
reveal a new role of Pyk2 in neuronal dysfunction. We
show that it is necessary for several components of the
depressive-like phenotype, which appears to require Pyk2-
dependent spine alterations in the amygdala. Thus, Pyk2
could be included in the list of molecules known as
negative modulators of resilience-like phenotypes against
chronic stress and depression, such as BDNF and
ΔFOSB30. Our findings indicate that targeting Pyk2 in
patients suffering from multiple and chronic stressful
psychological insults could help to prevent the associated
depressive symptoms. Since the activation state of Pyk2 in
the amygdala is not clearly altered in response to stress, it
could be particularly attractive to modulate the structural
role of Pyk2 without affecting its activity. Such structural
mechanism was already evoked in our previous paper18
and is reminiscent of that reported for the closely related
focal adhesion kinase (FAK) in non-neuronal cells69,70.
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This alternative signaling may be linked to scaffolding
properties of Pyk2 and/or its interaction with specific
partners. For instance, in our last paper, we showed that
although dendritic spines density was altered in Pyk2-
deficient neurons, it could be rescued by transfecting
either a mutant form of Pyk2 with a point mutation of the
autophosphorylation site or a kinase-dead Pyk2 with a
K457A mutation. However, transfection of a mutant form
of Pyk2 unable to bind to PSD-95 (Pyk21–840) could not
rescue the phenotype showing the importance of this
interaction in this particular pathway, which does not
involve the autophosphorylation of Pyk2. To sum up,
Pyk2 may function as a scaffold which gather some pro-
teins, independently of its kinase activity.
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